Joint venture https://www.bioworld.com/rss en-us MD Anderson Cancer Center, Radiopharm launch JV for radiopharmaceuticals http://www.bioworld.com/articles/689834 Tue, 20 Sep 2022 12:00:00 -0400 https://www.bioworld.com/articles/689834-md-anderson-cancer-center-radiopharm-launch-jv-for-radiopharmaceuticals Cancer diagnostic illustration MD Anderson Cancer Center, Radiopharm launch JV for radiopharmaceuticals http://www.bioworld.com/articles/689786 Mon, 19 Sep 2022 12:00:00 -0400 https://www.bioworld.com/articles/689786-md-anderson-cancer-center-radiopharm-launch-jv-for-radiopharmaceuticals Cancer diagnostic illustration Robocath’s Cathbot concludes initial study of robot-assisted PCI platform in China BioWorld.]]> http://www.bioworld.com/articles/521170 Fri, 29 Jul 2022 13:00:00 -0400 https://www.bioworld.com/articles/521170-robocaths-cathbot-concludes-initial-study-of-robot-assisted-pci-platform-in-china Surgeon operating the R-One system R-One, the robotic platform that optimizes the safety of robot-assisted coronary angioplasty. Credit: Robocath SAS. Biomérieux scales AMR focus through new joint venture http://www.bioworld.com/articles/520412 Wed, 06 Jul 2022 13:00:00 -0400 https://www.bioworld.com/articles/520412-biomerieux-scales-amr-focus-through-new-joint-venture Microbiome illustration Junshi and Immorna launch JV to develop mRNA therapeutics and vaccines http://www.bioworld.com/articles/509538 Tue, 20 Jul 2021 13:00:00 -0400 https://www.bioworld.com/articles/509538-junshi-and-immorna-launch-jv-to-develop-mrna-therapeutics-and-vaccines Hands holding gears Kinnate joins Orbimed to set up Shanghai JV for lung cancer drug http://www.bioworld.com/articles/507230 Tue, 18 May 2021 13:00:00 -0400 https://www.bioworld.com/articles/507230-kinnate-joins-orbimed-to-set-up-shanghai-jv-for-lung-cancer-drug Gold coins and sprouting plants Analytica expands into China with JV for urinary incontinence device http://www.bioworld.com/articles/505504 Fri, 02 Apr 2021 13:00:00 -0400 https://www.bioworld.com/articles/505504-analytica-expands-into-china-with-jv-for-urinary-incontinence-device Product image Pericoach system. Credit: Analytica Ltd. Belgium’s Etherna and China Grand Pharma set up joint venture to tap into mRNA vaccines http://www.bioworld.com/articles/500862 Wed, 02 Dec 2020 12:00:00 -0500 https://www.bioworld.com/articles/500862-belgiums-etherna-and-china-grand-pharma-set-up-joint-venture-to-tap-into-mrna-vaccines Generex establishes joint venture with Worldwide Digitech http://www.bioworld.com/articles/497151 Fri, 28 Aug 2020 13:00:00 -0400 https://www.bioworld.com/articles/497151-generex-establishes-joint-venture-with-worldwide-digitech Black and white arrows merging into one Zentalis Pharmaceuticals receives $20 million series A financing to set up Chinese JV http://www.bioworld.com/articles/435342 Tue, 26 May 2020 15:57:00 -0400 https://www.bioworld.com/articles/435342-zentalis-pharmaceuticals-receives-20-million-series-a-financing-to-set-up-chinese-jv Hands holding arrow-shaped puzzle pieces Zentalis Pharmaceuticals receives $20 million series A financing to set up Chinese JV http://www.bioworld.com/articles/435236 Wed, 20 May 2020 12:00:00 -0400 https://www.bioworld.com/articles/435236-zentalis-pharmaceuticals-receives-20-million-series-a-financing-to-set-up-chinese-jv Hands holding arrow-shaped puzzle pieces ‘It’s an incredibly challenging time’: Hoth, Voltron form Halovax to find COVID-19 vaccine http://www.bioworld.com/articles/433897 Mon, 23 Mar 2020 12:00:00 -0400 https://www.bioworld.com/articles/433897-its-an-incredibly-challenging-time-hoth-voltron-form-halovax-to-find-covid-19-vaccine Drug vial and syringe Vifor Pharma puts $28M into kidney disease JV with Evotec http://www.bioworld.com/articles/430958 Thu, 07 Nov 2019 00:00:00 -0500 https://www.bioworld.com/articles/430958-vifor-pharma-puts-28m-into-kidney-disease-jv-with-evotec Qurient inks joint venture with Max Planck Society and Lead Discovery Center in Germany http://www.bioworld.com/articles/430656 Wed, 30 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/430656-qurient-inks-joint-venture-with-max-planck-society-and-lead-discovery-center-in-germany Cleveland Clinic, American Well unveil venture http://www.bioworld.com/articles/430610 Tue, 22 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/430610-cleveland-clinic-american-well-unveil-venture Roy-Schoenberg-American-Well-cleveland-clinic.png Roy Schoenberg, president and CEO of American Well. Aslan and Bukwang set up JV to advance AhR antagonists http://www.bioworld.com/articles/429895 Wed, 09 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429895-aslan-and-bukwang-set-up-jv-to-advance-ahr-antagonists South Korea's Bioleaders and Israel's Weizmann found JV to advance p53-targeted R&D http://www.bioworld.com/articles/429900 Wed, 09 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429900-south-koreas-bioleaders-and-israels-weizmann-found-jv-to-advance-p53-targeted-rd South Korea's Celltrion builds Hong Kong biosimilar JV Vcell aimed at Chinese market http://www.bioworld.com/articles/343321 Mon, 22 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/343321-south-koreas-celltrion-builds-hong-kong-biosimilar-jv-vcell-aimed-at-chinese-market Binex, Zein to create JV backed by Chinese city of Chongqing http://www.bioworld.com/articles/349785 Wed, 03 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/349785-binex-zein-to-create-jv-backed-by-chinese-city-of-chongqing